ACS Chemical Biology · 2013 · 126 citations · 13 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingMolecular OncologyCancer Cell SignalingOncogenic Signaling PathwaysRas Family OncogenesSignal Transduction In CancerTargeted Cancer TherapyTyrosine Kinase InhibitorsCancer Signaling PathwaysCompound IdentificationEgfr InhibitionMap KinasesNatural Product PharmacologyOncogenic Ras MutationsRaf SignalingSomatic Mutations
One-third of all human cancers harbor somatic RAS mutations. This leads to aberrant activation of downstream signaling pathways involving the RAF kinases. Current ATP-competitive RAF inhibitors are active in cancers with somatic RAF mutations, such as BRAF(V600) mutant melanomas. However, they paradoxically promote the growth of RAS mutant tumors, partly due to the complex interplay between different homo- and heterodimers of A-RAF, B-RAF, and C-RAF. Based on pathway analysis and structure-guided compound identification, we describe the natural product cotylenin-A (CN-A) as stabilizer of the physical interaction of C-RAF with 14-3-3 proteins. CN-A binds to inhibitory 14-3-3 interaction sites of C-RAF, pSer233, and pSer259, but not to the activating interaction site, pSer621. While CN-A alone is inactive in RAS mutant cancer models, combined treatment with CN-A and an anti-EGFR antibody synergistically suppresses tumor growth in vitro and in vivo. This defines a novel pharmacologic strategy for treatment of RAS mutant cancers.
13
Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman, Kevin B. Kim, Lynn M. Schuchter et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text
Medicine, Oncology, Pharmacology +16
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos, Chao Zhang, Gideon Bollag et al. · Nature · 2010 · 1.8K citations · Full text
Structure of the FKBP12-Rapamycin Complex Interacting with Binding Domain of Human FRAP
Jung‐Won Choi, Jie Chen, Stuart L. Schreiber et al. · Science · 1996 · 930 citations
Brefeldin A Acts to Stabilize an Abortive ARF–GDP–Sec7 Domain Protein Complex
Anne Peyroche, Bruno Antonny, Sylviane Robineau et al. · Molecular Cell · 1999 · 446 citations · Full text